AusBiotech appoints Dr Dean Moss as Director
AusBiotech announced the appointment of Dr Dean Moss as a Director – an addition that brings strong global and commercialisation experience to the AusBiotech Board - and the departure of Lawrence Gozlan, at its Annual General Meeting. Dr Dean Moss brings to AusBiotech more than 30 years’ of global experience in science, academia, business, management and commercialisation in Australia, the US and the UK. Dr Moss is currently the CEO of UniQuest, Australia’s leading university commercialisation entity, managing the intellectual property of The University of Queensland. He is a board member of several Australian biotechnology companies and was a member of the investment committee of the pre-seed venture funds Uniseed, the Medical Research Commercialisation Fund and the New Zealand Government’s KiwiNet. He has been Managing Director or Senior Business Development Executive of several health and biotech companies worldwide.